Basic Information
Basic information for CPB2-AS1-213-17aa-4
Peptide Name CPB2-AS1-213-17aa-4
Genome Position chr13:46113580-46113630[+]
Species Human
Peptide Sequence MWEGYREITRYGAVSQE
Peptide Length 17
Unique No (CPB2-AS1-201-17aa-1,CPB2-AS1-206-17aa-1,CPB2-AS1-210-17aa-2,CPB2-AS1-214-17aa-1,CPB2-AS1-215-17aa-2,CPB2-AS1-218-17aa-1)
Grand Average of Hydropathicity -0.9647
Relative Molecular Mass 2363.55
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000235903;CPB2-AS1
Transcript ID/Name ENST00000664417;CPB2-AS1-213
Transcript Length 4368
Coding Ability 0.3615
DNA Sequence Corresponding to Peptide ATGTGGGAAGGGTATAGGGAAATTACAAGGTATGGTGCAGTGTCCCAAGAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :